SGLT2 Inhibitors Reduce CV Death or HF Hospitalization in T2DM Tags Myocardial infarction SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Reduce CV Death or HF Hospitalization in T2DM
SGLT2i Use Tied to Lower Mortality in T2DM Across Ethnicities Tags Coronary artery disease SGLT-2 Inhibitor Read more about SGLT2i Use Tied to Lower Mortality in T2DM Across Ethnicities
Anagliptin Improved HbA1c Added to Metformin and Empagliflozin Tags hBA1c DPP-4 inhibitors Biguanide SGLT-2 Inhibitor Read more about Anagliptin Improved HbA1c Added to Metformin and Empagliflozin
Finerenone Benefit Persisted Across Baseline Diabetes Care Goals Tags Lipoprotein(a) hBA1c GLP-1 agonists SGLT-2 Inhibitor Read more about Finerenone Benefit Persisted Across Baseline Diabetes Care Goals
SGLT2i in Cardio-Renal Care: Bridging Heart & Kidney Protection Tags SGLT-2 Inhibitor Read more about SGLT2i in Cardio-Renal Care: Bridging Heart & Kidney Protection
Metabolic Shifts & Cardiovascular Foundations: The Expanding Role of SGLT2i Inhibitors Tags SGLT-2 Inhibitor Read more about Metabolic Shifts & Cardiovascular Foundations: The Expanding Role of SGLT2i Inhibitors
Dapagliflozin Added to Valsartan Improved Cardiorenal Measures in T2DM Tags SGLT-2 Inhibitor Read more about Dapagliflozin Added to Valsartan Improved Cardiorenal Measures in T2DM
TZD and SGLT2i Outperform DPP-4i After Revascularization in T2DM Tags Myocardial infarction Peripheral vascular disease Stroke DPP-4 inhibitors Thiazolidinediones Read more about TZD and SGLT2i Outperform DPP-4i After Revascularization in T2DM
Petrelintide Showed Weight Loss With Low GI Events Tags Amylin analogue Read more about Petrelintide Showed Weight Loss With Low GI Events
SGLT2 Inhibitors Reduced Rejection After Heart Transplant Tags SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Reduced Rejection After Heart Transplant